Much of CCOAT’s work has a drug-safety focus, from our drug interaction and first in human trials, our work with single low-dose primaquine and our methodology research. This has led to us conceiving and coordinating an open-access pharmacovigilance platform within the Global Health Network where those in low and middle-income countries may share experiences, knowledge and tools relating to pharmacovigilance and other patient/research participant safety-related issues.